Which stocks are leading the Nasdaq-100 higher in 2024? This diverse bunch of leaders is taking the market by storm.

--Off 0.99% from its 52-week high of 19298.76 hit Monday, Nov. 11, 2024 --Up 35.38% from its 52-week low of 14113.67 hit Thursday, Nov. 16, 2023 --Rose 35.38% from 52 weeks ago --Off 0.99% from its ...

(RTTNews) - Chart Industries Inc. (GTLS ... views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

This partnership adds convenience and new services for Coinbase customers across the U.S. and EU, including real-time, reliable, and secure money movement. By integrating with the Visa Direct ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Nasdaq made waves earlier this month as the company jumped into the upper echelon of risk and compliance organizations with a series of honors at the sector’s premier annual awards. Nasdaq ...

In early trading on Tuesday, shares of Cadence Design Systems topped the list of the day's best performing components of the Nasdaq 100 index, trading up 9.2%. Year to date, Cadence Design Systems ...

The benchmark FTSE 100 was up 27 points ... views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...

What is a PE Ratio? The PE Ratio chart for Nasdaq 100 Index (NDX ) is a valuation observation. A PE Ratio is a price to earnings ratio that has historically helped investors define fair value. This is ...

In early trading on Monday, shares of Moderna topped the list of the day's best performing components of the Nasdaq 100 index, trading up 2.4%. Year to date, Moderna has lost about 45.3% of its value.